The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Summer Symposium 2018

Breakthrough Cancer Nanotechnologies

On June 15, 2018, MIT’s Koch Institute for Integrative Cancer Research will present its 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies. Nanomedicine is a converging field of study in biology and engineering where scientists work at the molecular level to engineer innovative approaches to better detect, monitor, and treat cancer. Experts will discuss how nanotechnology can provide rapid and sensitive detection of cancer, as well as generate entirely novel and highly effective therapeutic agents. The symposium will also feature an industry panel to discuss the impact of nanomedicine on the future of cancer care.

Registration opening in spring 2018 — stay tuned!

For sponsorship opportunities, email Leny Gocheva at gochevav@mit.edu.

FEATURED SPEAKERS AND PANELISTS


Noubar Afeyan

 

Noubar Afeyan
Founder and CEO, Flagship Pioneering
 

Daniel Anderson

 

Daniel Anderson, PhD
Samuel A. Goldblith Professor of Applied Biology, MIT
Associate Professor, Chemical Engineering and Institute for Medical Engineering and Science, MIT
Member, Koch Institute, MIT

Angela Belcher

 

Angela Belcher, PhD

James Mason Crafts Professor and Professor of Biological Engineering, MIT
Member, Koch Institute, MIT

Sangeeta Bhatia

 

Sangeeta Bhatia, MD, PhD
Director, Marble Center for Cancer Nanomedicine
John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science, MIT
Member, Koch Institute, MIT
Investigator, Howard Hughes Medical Institute

Michelle S. Bradbury, MD, PhD

 

Michelle S. Bradbury, MD, PhD
Co-Director, MSK-Cornell Center for Translation of Cancer Nanomedicines & Director, Intraoperative Imaging Program
Member, Molecular Pharmacology Program, Sloan Kettering Institute
Attending, Radiology, Memorial Sloan Kettering Cancer Center
Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences & Weill Medical College of Cornell University

Mark E. Davis, PhD

 

Mark E. Davis, PhD  
Professor of Chemical Engineering and Nanomedicine, University of Southern California

Sanjiv Sam Gambhir, MD, PhD

 

Sanjiv Sam Gambhir, MD, PhD  
Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research, Professor of Bioengineering, Professor of Materials Science and Engineering, Stanford University

Paula Hammond

 

Paula Hammond, PhD
Head, Department of Chemical Engineering, MIT
David H. Koch Professor of Engineering, MIT
Member, Koch Institute, MIT

James R. Heath

 

James R. Heath, PhD
President and Professor, Institute for Systems Biology
Professor of Molecular and Medical Pharmacology, UCLA

Robert Langer

 

Robert Langer, ScD
David H. Koch Institute Professor
Member, Koch Institute, MIT

John Maraganore

 

John Maraganore, PhD
CEO and Director, Alnylam

Suzie H. Pun

 

Suzie H. Pun, PhD
Robert F. Rushmer Professor of Bioengineering, Adjunct Professor of Chemical Engineering, University of Washington

Mehmet Toner

 

Mehmet Toner, PhD
Helen Andrus Benedict Professor of Biomedical Engineering, Harvard Medical School
Founding Co-Director, The Institute for Bioengineering and Biotechnology, a division of Surgery at the Massachusetts General Hospital
Director, BioMEMS Center, Massachusetts General Hospital

Ralph Weissleder

 

Ralph Weissleder, MD, PhD
Thrall Professor of Radiology and Professor of Systems Biology, Harvard Medical School
Director of the Center for Systems Biology at Massachusetts General Hospital